Liangwei Wang

7PUBLICATIONS
20CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biologyGenetically modified animalsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 03, 2025
Metabolic Reprogramming in Epstein-Barr Virus Associated Diseases.

Tiffany Melanie Yee, Liang Wei Wang

|Jun 10, 2024
Multi-omic Analysis of Human B-cell Activation Reveals a Key Lysosomal BCAT1 Role in mTOR Hyperactivation by B-cell receptor and TLR9.

Benjamin Gewurz, Rui Guo, Matthew Lim

|Jul 14, 2023
Targeting Metabolic Vulnerabilities in Epstein-Barr Virus-Driven Proliferative Diseases.

Nicole Yong Ting Leung, Liang Wei Wang

|Feb 26, 2022
Human Milk Antibodies after BNT162b2 Vaccination Exhibit Reduced Binding against SARS-CoV-2 Variants of Concern.

Jia Ming Low, Yue Gu, Melissa Shu Feng Ng

|Aug 20, 2021
Codominant IgG and IgA expression with minimal vaccine mRNA in milk of BNT162b2 vaccinees.

Jia Ming Low, Yue Gu, Melissa Shu Feng Ng

|Sep 14, 2019
Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival.

Liang Wei Wang, Zhonghao Wang, Ina Ersing

Pageof 2

Frequent Collaborators

2 joint publications

Rui Guo

2 joint publications

Zubair Amin

2 joint publications

Youjia Zhong

1 joint publications

Luis Nobre